RSLS Live signaler | Maksimer profitt med Getagraph.com

KJøP 127513 min ago

@ $0.190

Utstedt: 6 feb 2024 @ 17:13

Avkastning: -10.89%

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	72 737.00
Gjennomsnittsvolum	486 227
Markedsverdi	3.97M
EPS	$-0.110 ( 2024-04-15 )
Neste inntjeningsdato	( $-0.160 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00300 (1.75%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Schneid Yair	Sell	0	Common Stock
2023-08-04	Stankovich Thomas	Sell	108	Common Stock, $0.001 par value per share
2023-08-24	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share
2023-09-01	Stankovich Thomas	Sell	118	Common Stock, $0.001 par value per share
2023-10-11	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share

INSIDER POWER
-2.79
Last 95 transactions
Buy: 10 386 223 \| Sell: 2 711 639

Volum Korrelasjon

Lang: 0.13 (neutral)

Kort: 0.25 (neutral)

Signal:(49.501) Neutral

ReShape Lifesciences Inc Korrelasjon

10 Mest positive korrelasjoner
LGVN	0.931
PAIC	0.919
CNSP	0.911
HJLIW	0.908
AXDX	0.903
PCSA	0.902
AGRI	0.901
KXIN	0.901
DXYN	0.901
EBIX	0.898

10 Mest negative korrelasjoner
NETE	-0.922
BRIVU	-0.914
AMRB	-0.906
STAY	-0.901
NVCN	-0.899
SILK	-0.897
MSDA	-0.896
CGEM	-0.895
RAVN	-0.893
TIOA	-0.89

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

ReShape Lifesciences Inc Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.59
( weak negative )

ReShape Lifesciences Inc Økonomi

Annual	2023
Omsetning:	$8.68M
Bruttogevinst:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2023
Omsetning:	$8.68M
Bruttogevinst:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2022
Omsetning:	$11.24M
Bruttogevinst:	$6.80M (60.52 %)
EPS:	$-108.90

FY	2021
Omsetning:	$13.60M
Bruttogevinst:	$8.35M (61.38 %)
EPS:	$-250.16

Financial Reports:

No articles found.

ReShape Lifesciences Inc

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.